Anaplastic Large Cell Lymphoma - Histology

Relevant Publications

Identification of APPB1 as a substrate for anaplastic lymphoma kinase.

Issue Release: 2024

Anaplastic Large-cell Lymphoma in Children: State of the Art in 2023.

Issue Release: 2024

Population modeling analyses of crizotinib in pediatric patients with ALK-positive advanced cancers.

Issue Release: 2024

Malignancy-Associated Secondary Hemophagocytic Lymphohistiocytosis Mimicking an Infection: A Case Report and Review of the Literature.

Issue Release: 2024

Metastases and Primary Brain Tumors Affecting the Fornix of the Brain.

Issue Release: 2024

Undifferentiated Pleomorphic Sarcoma Mimicking Breast Implant-Associated Anaplastic Large Cell Lymphoma.

Issue Release: 2024

Establishment and characterization of TK-ALCL1: a novel NPM-ALK-positive anaplastic large-cell lymphoma cell line.

Issue Release: 2024

Brentuximab Vedotin Retreatment in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma or Peripheral T-Cell Lymphoma: A Retrospective United States Claims Analysis.

Issue Release: 2024

Breast lymphomas: Clinical and pathological insights from a tertiary cancer care center in India.

Issue Release: 2024

Late Hematoma After Feminizing Augmentation Mammoplasty Mimicking Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).

Issue Release: 2024

Spider Bite Presenting as Fever, Macrophage Activation Syndrome and a Skin Ulcer.

Issue Release: 2024

EBV-positive Nodal T-Cell and NK-Cell Lymphoma: A Study of 26 Cases Including a Subset With Strong CD30 Expression Mimicking Anaplastic Large Cell Lymphoma.

Issue Release: 2024

Plasmablastic Lymphoma. A State-of-the-Art Review: Part 1-Epidemiology, Pathogenesis, Clinicopathologic Characteristics, Differential Diagnosis, Prognostic Factors, and Special Populations.

Issue Release: 2024

Our Experience in Diagnosing and Treating Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).

Issue Release: 2024

Hematopoietic stem cell transplantation for pediatric patients with non-anaplastic peripheral T-cell lymphoma. An EBMT pediatric diseases working party study.

Issue Release: 2024

Dramatic progression of multifocal primary cutaneous anaplastic large-cell lymphoma.

Issue Release: 2024

Update on T-Cell Lymphoma Epidemiology.

Issue Release: 2024

Case report: The utilization of crizotinib and brentuximab vedotin as a bridge to autologous stem cell transplantation and followed by CD30-directed CAR-T cell therapy in relapsed/refractory ALK+ ALCL.

Issue Release: 2024

Isolated Central Nervous System Involvement after Brentuximab Vedotin Treatment for HIV-Positive ALK-Negative Anaplastic Large Cell Lymphoma.

Issue Release: 2024

Impact of tumor-intrinsic molecular features on survival and acquired tyrosine kinase inhibitor resistance in ALK-positive NSCLC.

Issue Release: 2024

What is Ferritin?

What safety considerations are associated with histology instruments?

How Are Diagnostic Errors Identified?

Are There Any Other Diagnostic Features of Papillary Thyroid Carcinoma?

What Challenges are Faced in Protein Purification?

Can TCM and histology complement each other in modern medicine?

How are Paraffin Sections Stained?

What is von Willebrand Factor (vWF)?

Why is Ultrastructure Important?

What is Phenylketonuria (PKU)?

Partnered Content Networks

Relevant Topics